Prelude Capital Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,193
| Closed | -$263K | – | 1241 |
|
|
2023
Q4 | $263K | Buy |
+12,193
| New | +$263K | 0.02% | 695 |
|
|
2023
Q2 | – | Sell |
-23,144
| Closed | -$526K | – | 1052 |
|
|
2023
Q1 | $526K | Hold |
23,144
| – | – | 0.03% | 398 |
|
|
2022
Q4 | $545K | Hold |
23,144
| – | – | 0.03% | 478 |
|
|
2022
Q3 | $604K | Buy |
23,144
+86
| +0.4% | +$2.24K | 0.02% | 568 |
|
|
2022
Q2 | $506K | Buy |
23,058
+15,591
| +209% | +$342K | 0.01% | 677 |
|
|
2022
Q1 | $335K | Buy |
7,467
+1,612
| +28% | +$72.3K | 0.01% | 813 |
|
|
2021
Q4 | $251K | Buy |
5,855
+707
| +14% | +$30.3K | 0.01% | 1112 |
|
|
2021
Q3 | $342K | Buy |
5,148
+5
| +0.1% | +$332 | 0.01% | 805 |
|
|
2021
Q2 | $377K | Buy |
+5,143
| New | +$377K | 0.01% | 875 |
|
|
2020
Q1 | – | Sell |
-24,101
| Closed | -$828K | – | 1045 |
|
|
2019
Q4 | $828K | Hold |
24,101
| – | – | 0.03% | 230 |
|
|
2019
Q3 | $436K | Buy |
+24,101
| New | +$436K | 0.02% | 300 |
|